Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ixazomib treatment has a dual effect on bone remodeling in patients with multiple myeloma: follow-up results from a phase 2 clinical study

Bone(2025)10.1016/j.bone.2025.117660Source: DataRank Database

Ixazomib treatment has a dual effect on bone remodeling in patients with multiple myeloma: follow-up results from a phase 2 clinical study is a research paper published in Bone (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access0 citations

Free full text

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT04028115

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: hybridTopics (35)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Marta Diaz‐delCastillo ORCID,Michael Tveden Gundesen ORCID,Oriane Cédile ORCID,Christian Walther Andersen ORCID,Anne Lerberg Nielsen ORCID

Live enrichment

PubMed:40998041 OpenAlex:https://openalex.org/W4414564453

Foundation for the National Institutes of Health

Grant: AG075227

FWCI

0.00

Citation Percentile

0.3%

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.bone.2025.117660

publisherhttps://doi.org/10.1016/j.bone.2025.117660

publisherhttps://api.elsevier.com/content/article/PII:S8756328225002728?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S8756328225002728?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40998041

Fields of Study

Multiple Myeloma Research and TreatmentsBone health and treatmentsHumansMultiple MyelomaBoron CompoundsGlycineBone RemodelingMaleFemaleAgedMiddle AgedFollow-Up Studies

MeSH Terms

AgedBoron CompoundsFemaleFollow-Up StudiesGlycineHumansMaleMiddle AgedMultiple MyelomaBone Remodeling

Keywords

IxazomibBone resorptionMultiple myelomaBone remodelingOsteoporosisProteasome inhibitorBone diseaseOsteoblastClinical trialAnabolicHistologyHistomorphometryMyeloma bone disease